As Indonesia rolls out its COVID-19 inoculation program for second priority recipients, public doubt remains a challenge alongside the limited vaccine supply.
The latest survey by the Centre for Strategic and International Studies-Jakarta (CSIS) found that 42.5 percent of respondents in the nation’s capital said they either strongly or moderately distrusted the efficacy of COVID-19 vaccines. In the cultural hub of Yogyakarta, the figure was 29.5 percent.
In Jakarta, 40 percent of all respondents said they did not want to be vaccinated, while 27.5 percent of respondents in Yogyakarta said the same.
"These figures are not ideal, even more so at a time when the second stage of the vaccination program is being rolled out for essential workers and the vulnerable age group," CSIS researcher ...
Starting from IDR 55,000/month